Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against staphylococcus aureus biofilms

Frontiers in Microbiology

Volumn 9, Issue FEB, 2018, Pages

  Kumaran, Dilini ^a   Taha, Mariam ^a   Yi, QiLong ^b   Ramirez Arcos, Sandra ^b   Diallo, Jean Simon ^a   Carli, Alberto ^c   Abdelbary, Hesham ^a,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Antibiotics; Bacteriophage; Biofilm; Staphylococcus aureus; Synergy

Indexed keywords

CEFAZOLIN; DICLOXACILLIN; LINEZOLID; TETRACYCLINE; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIOPHAGE; BIOFILM; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS;

EID: 85041844996     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2018.00127     Document Type: Article

References (40)

1. Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., and Shirtliff, M. E. (2011). Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2, 445-459. doi: 10.4161/viru.2.5.17724
2. Bedi, M. S., Verma, V., and Chhibber, S. (2009). Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World J. Microbiol. Biotechnol. 25, 1145-1151. doi: 10.1007/s11274-009-9991-8
3. Burrowes, B., Harper, D. R., Anderson, J., McConville, M., and Enright, M. C. (2011). Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev. Anti Infect. Ther. 9, 775-785. doi: 10.1586/eri.11.90
4. Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., and Turner, P. E. (2016). Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci. Rep. 6:26717. doi: 10.1038/srep26717
5. Chaudhry, W. N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J. J., and Levin, B. R. (2017). Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms. PLOS ONE 12:e0168615. doi: 10.1371/journal.pone.0168615
6. Chhibber, S., Kaur, T., and Kaur, S. (2013). Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections. PLOS ONE 8:e56022. doi: 10.1371/journal.pone.0056022
7. Clinical Laboratory Standards Institute [Clsi]. (2015). M07-A10 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 10th Edn. Wayne, PA: Clinical Laboratory Standards Institute
8. Comeau, A. M., Tétart, F., Trojet, S. N., Prere, M. F., and Krisch, H. M. (2007). Phage-antibiotic synergy (PAS): β-lactam and quinolone antibiotics stimulate virulent phage growth. PLOS ONE 2:e799. doi: 10.1371/journal.pone.0000799
9. Cornelissen, A., Ceyssens, P. J., T'syen, J., Van Praet, H., Noben, J. P., Shaburova, O. V., et al. (2011). The T7-related Pseudomonas putida phage f15 displays virion-associated biofilm degradation properties. PLOS ONE 6:e18597. doi: 10.1371/journal.pone.0018597
10. Costerton, J. W., Stewart, P. S., and Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322. doi: 10.1126/science.284.5418.1318
11. Cui, H., Ma, C., and Lin, L. (2016). Co-loaded proteinase K/thyme oil liposomes for inactivation of Escherichia coli O157: H7 biofilms on cucumber. Food Funct. 7, 4030-4040. doi: 10.1039/C6FO01201A
12. Doolittle, M. M., Cooney, J. J., and Caldwell, D. E. (1996). Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J. Ind. Microbiol. 16, 331-341. doi: 10.1007/BF01570111
13. Doss, J., Culbertson, K., Hahn, D., Camacho, J., and Barekzi, N. (2017). A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms. Viruses 9:E50. doi: 10.3390/v9030050
14. Escobar-Páramo, P., Gougat-Barbera, C., and Hochberg, M. E. (2012). Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage. Evol. Appl. 5, 583-592. doi: 10.1111/j.1752-4571.2012.00248.x
15. Fauvart, M., De Groote, V. N., and Michiels, J. (2011). Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 60, 699-709. doi: 10.1099/jmm.0.030932-0
16. Gordon, C. A., Hodges, N. A., and Marriott, C. (1988). Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J. Antimicrob. Chemother. 22, 667-674. doi: 10.1093/jac/22.5.667
17. Gutiérrez, D., Martínez, B., Rodríguez, A., and García, P. (2012). Genomic characterization of two Staphylococcus epidermidis bacteriophages with anti-biofilm potential. BMC Genomics 13:228. doi: 10.1186/1471-2164-13-228
18. Kaur, S., Harjai, K., and Chhibber, S. (2016). In Vivo assessment of phage and linezolid based implant coatings for treatment of methicillin resistant Staphylococcus aureus (MRSA) mediated orthopaedic device related infections. PLOS ONE 11:e0157626. doi: 10.1371/journal.pone.0157626
19. Lauderdale, K. J., Malone, C. L., Boles, B. R., Morcuende, J., and Horswill, A. R. (2010). Biofilm dispersal of community-associated methicillin-resistant Staphylococcus aureus on orthopedic implant material. J. Orthop. Res. 28, 55-61. doi: 10.1002/jor.20943
20. Lebeaux, D., Ghigo, J. M., and Beloin, C. (2014). Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol. Mol. Biol. Rev. 78, 510-543. doi: 10.1128/MMBR.00013-14
21. Lister, J. L., and Horswill, A. R. (2014). Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front. Cell. Infect. Microbiol. 4:178. doi: 10.3389/fcimb.2014.00178
22. Loc-Carrillo, C., and Abedon, S. T. (2011). Pros and cons of phage therapy. Bacteriophage 1, 111-114. doi: 10.4161/bact.1.2.14590
23. Lynch, S. V., Dixon, L., Benoit, M. R., Brodie, E. L., Keyhan, M., Hu, P., et al. (2007). Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms. Antimicrob. Agents Chemother. 51, 3650-3658. doi: 10.1128/AAC.00601-07
24. MacNeal, W. J., and Frisbee, F. C. (1936). One hundred patients with Staphylococcus septicemia receiving bacteriophage service. Am. J. Med. Sci. 191, 179-195. doi: 10.1097/00000441-193602000-00004
25. Mah, T. F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., and O'toole, G. A. (2003). A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426, 306-310. doi: 10.1038/nature02122
26. Mah, T. F. C., and O'Toole, G. A. (2001). Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9, 34-39. doi: 10.1016/S0966-842X(00)01913-2
27. National Institute of Health [NIH]. (2007). Department of Health and Human Services. Immunology of Biofilms. Available at: http://grants.nih.gov/grants/guide/pa-files/PA-07-288.html [accessed November 08, 2017]
28. Parasion, S., Kwiatek, M., Gryko, R., Mizak, L., and Malm, A. (2014). Bacteriophages as an alternative strategy for fighting biofilm development. Pol. J. Microbiol. 63, 137-145
29. Payne, R. J., and Jansen, V. A. (2000). Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. Clin. Pharmacol. Ther. 68, 225-230. doi: 10.1067/mcp.2000.109520
30. Pearl, S., Gabay, C., Kishony, R., Oppenheim, A., and Balaban, N. Q. (2008). Nongenetic individuality in the host-phage interaction. PLOS Biol. 6:e120. doi: 10.1371/journal.pbio.0060120
31. Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., and Hancock, R. E. (2014). A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob. Agents Chemother. 58, 5363-5371. doi: 10.1128/AAC.03163-14
32. Römling, U., and Balsalobre, C. (2012). Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med. 272, 541-561. doi: 10.1111/joim.12004
33. Salmond, G. P., and Fineran, P. C. (2015). A century of the phage: past, present and future. Nat. Rev. Microbiol. 3, 777-786. doi: 10.1038/nrmicro3564
34. Schultz, E. W. (1929). The bacteriophage as a therapeutic agent. Cal. West. Med. 31, 5-10
35. Tande, A. J., and Patel, R. (2014). Prosthetic joint infection. Clin. Microbiol. Rev. 27, 302-345. doi: 10.1128/CMR.00111-13
36. Torres-Barceló, C., Arias-Sánchez, F. I., Vasse, M., Ramsayer, J., Kaltz, O., and Hochberg, M. E. (2014). A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages. PLOS ONE 9:e106628. doi: 10.1371/journal.pone.0106628
37. Verma, V., Harjai, K., and Chhibber, S. (2009). Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J. Antimicrob. Chemother. 64, 1212-1218. doi: 10.1093/jac/dkp360
38. Verma, V., Harjai, K., and Chhibber, S. (2010). Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling 26, 729-737. doi: 10.1080/08927014.2010.511196
39. Yilmaz, C., Colak, M., Yilmaz, B. C., Ersoz, G., Kutateladze, M., and Gozlugol, M. (2013). Bacteriophage Therapy in Implant-Related Infections: an experimental study. J. Bone. Joint. Surg. Am. 95, 117-125. doi: 10.2106/JBJS.K.01135
40. Zhang, Q. G., and Buckling, A. (2012). Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. Evol. Appl. 5, 575-582. doi: 10.1111/j.1752-4571.2011.00236.x